Evolus, Inc. EVL.F Stock
Evolus, Inc. Price Chart
Evolus, Inc. EVL.F Financial and Trading Overview
| Evolus, Inc. stock price | 11.7 EUR |
| Previous Close | 8.5 EUR |
| Open | 8.65 EUR |
| Bid | 8.7 EUR x 0 |
| Ask | 8.85 EUR x 0 |
| Day's Range | 8.65 - 8.65 EUR |
| 52 Week Range | 6.05 - 10.5 EUR |
| Volume | 275 EUR |
| Avg. Volume | 8 EUR |
| Market Cap | 492.45M EUR |
| Beta (5Y Monthly) | 1.640457 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.14 EUR |
EVL.F Valuation Measures
| Enterprise Value | 547.92M EUR |
| Trailing P/E | N/A |
| Forward P/E | -41.190475 |
| PEG Ratio (5 yr expected) | -0.75 |
| Price/Sales (ttm) | 2.9206035 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3.25 |
| Enterprise Value/EBITDA | -13.529 |
Trading Information
Evolus, Inc. Stock Price History
| Beta (5Y Monthly) | 1.640457 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 10.5 EUR |
| 52 Week Low | 6.05 EUR |
| 50-Day Moving Average | 7.54 EUR |
| 200-Day Moving Average | 7.83 EUR |
EVL.F Share Statistics
| Avg. Volume (3 month) | 8 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 56.92M |
| Float | 39.9M |
| Short Ratio | N/A |
| % Held by Insiders | 23.83% |
| % Held by Institutions | 71.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -39.36% |
| Operating Margin (ttm) | -26.62% |
| Gross Margin | 68.14% |
| EBITDA Margin | -24.019% |
Management Effectiveness
| Return on Assets (ttm) | -14.77% |
| Return on Equity (ttm) | -332.70% |
Income Statement
| Revenue (ttm) | 168.61M EUR |
| Revenue Per Share (ttm) | 2.99 EUR |
| Quarterly Revenue Growth (yoy) | 32.80% |
| Gross Profit (ttm) | 92.73M EUR |
| EBITDA | -40500000 EUR |
| Net Income Avi to Common (ttm) | -66371000 EUR |
| Diluted EPS (ttm) | -1.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.71M EUR |
| Total Cash Per Share (mrq) | 0.73 EUR |
| Total Debt (mrq) | 96.82M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.333 |
| Book Value Per Share (mrq) | -0.122 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -59722000 EUR |
| Levered Free Cash Flow (ttm) | -34738624 EUR |
Profile of Evolus, Inc.
| Country | Germany |
| State | CA |
| City | Newport Beach |
| Address | 520 Newport Center Drive |
| ZIP | 92660 |
| Phone | 949 284 4555 |
| Website | https://www.evolus.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 215 |
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Q&A For Evolus, Inc. Stock
What is a current EVL.F stock price?
Evolus, Inc. EVL.F stock price today per share is 11.7 EUR.
How to purchase Evolus, Inc. stock?
You can buy EVL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evolus, Inc.?
The stock symbol or ticker of Evolus, Inc. is EVL.F.
Which industry does the Evolus, Inc. company belong to?
The Evolus, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Evolus, Inc. have in circulation?
The max supply of Evolus, Inc. shares is 61.5M.
What is Evolus, Inc. Price to Earnings Ratio (PE Ratio)?
Evolus, Inc. PE Ratio is now.
What was Evolus, Inc. earnings per share over the trailing 12 months (TTM)?
Evolus, Inc. EPS is -1.01 EUR over the trailing 12 months.
Which sector does the Evolus, Inc. company belong to?
The Evolus, Inc. sector is Healthcare.